Godrej Agrovet confirms no encumbrance on Astec shares in FY26

1 min read     Updated on 23 Jun 2026, 04:35 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Godrej Agrovet Limited and its promoter group confirmed no encumbrance on Astec LifeSciences shares for FY26, complying with SEBI regulations.

powered bylight_fuzz_icon
43460153

*this image is generated using AI for illustrative purposes only.

Godrej Agrovet Limited, along with persons acting in concert, has confirmed that it has not created any encumbrance on its shareholding in astec lifesciences during the Financial Year 2025-26. This disclosure ensures that the promoter's holdings remain free from charges such as pledges or liens, which is critical for maintaining shareholder confidence and regulatory compliance.

The confirmation was submitted to BSE Limited and National Stock Exchange of India Limited on April 9, 2026. The filing was made in compliance with Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation mandates promoters to disclose any encumbrance on their shareholding to ensure transparency in the capital markets.

The declaration covers Godrej Agrovet Limited and the extensive promoter group, including key individuals such as Nadir Barjorji Godrej, Adi Barjorji Godrej, and Nisaba Godrej. It also encompasses various group entities and trusts, confirming that no direct or indirect encumbrance was made on the shares during the specified financial year.

Entity Role Status
Godrej Agrovet Limited Promoter No Encumbrance
Nadir Barjorji Godrej Promoter No Encumbrance
Adi Barjorji Godrej Promoter No Encumbrance
Nisaba Godrej Promoter Group No Encumbrance
Godrej Industries Limited Promoter No Encumbrance

The disclosure was signed by Vivek Raizada, Head – Legal & Company Secretary & Compliance Officer, and submitted from Mumbai. This regulatory filing is part of the ongoing compliance requirements listed under the SEBI Takeover Regulations.

Historical Stock Returns for Astec Lifesciences

1 Day5 Days1 Month6 Months1 Year5 Years
-3.52%-8.11%-6.01%+1.22%-11.32%-44.90%

How might this clean shareholding status influence Godrej Agrovet's ability to raise capital for future acquisitions?

What impact will this disclosure have on shareholder confidence and Astec Lifesciences' stock performance?

Could this move signal potential strategic shifts or expansion plans by Godrej Agrovet in the agrochemical sector?

Astec LifeSciences accepts GM-HR resignation to pursue new role

1 min read     Updated on 06 Jun 2026, 01:36 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Astec LifeSciences Limited accepted the resignation of Ms. Vijayalakshmi Iyer as General Manager – Human Resources effective June 5, 2026, to pursue a new opportunity. The company confirmed no other material reasons for the resignation.

powered bylight_fuzz_icon
42211780

*this image is generated using AI for illustrative purposes only.

Astec LifeSciences Limited has accepted the resignation of Ms. Vijayalakshmi Iyer from the position of General Manager – Human Resources. The resignation, tendered on June 5, 2026, was submitted to pursue a new opportunity and has been accepted by the Board of Directors. The company confirmed there are no other material reasons for the resignation beyond the stated career move.

The disclosure was made to the stock exchanges pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was signed by Tejashree Pradhan, Company Secretary & Compliance Officer, and submitted to BSE Limited and National Stock Exchange of India Limited.

Resignation Details

The following table outlines the key particulars of the cessation of the senior management personnel:

Sr. No. Particulars Details
1. Reason for change Resignation to pursue a new opportunity
2. Date of Cessation June 5, 2026
3. Brief Profile Not Applicable
4. Disclosure of relationships Not Applicable

In her resignation letter, Ms. Iyer expressed her commitment to ensuring a smooth transition during her notice period. She stated she would work closely with the team to complete key deliverables and support the handover process effectively. She also extended her gratitude to the organization for the opportunities provided during her tenure.

Historical Stock Returns for Astec Lifesciences

1 Day5 Days1 Month6 Months1 Year5 Years
-3.52%-8.11%-6.01%+1.22%-11.32%-44.90%

Who will be appointed to succeed Ms. Iyer and what is the expected timeline for this transition?

How will this leadership change impact Astec LifeSciences' ongoing HR initiatives and talent retention strategies?

Will the company face any increased operational risks during the interim period before a new General Manager is onboarded?

More News on Astec Lifesciences

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-11.32%